ACI
HAE icon

AMP Capital Investors’s Haemonetics HAE Stock Holding History

AMP Capital Investors’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-2,667
Closed -$302K – 1144
2018
Q3 		$302K Sell
2,667
-9,862
-79% -$1.02M ﹤0.01% 1078
2018
Q2 		$1.12M Buy
+12,529
New +$1.06M 0.01% 866
2017
Q4 		– Sell
-9,400
Closed -$422K – 1200
2017
Q3 		$422K Buy
+9,400
New +$391K ﹤0.01% 1015

Other funds holding HAE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
HM
HealthCor Management New York $109M AUM 10.64% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

AMP Capital Investors's HAE Position: Q4 2018 in Review

AMP Capital Investors sold out of Haemonetics (HAE) in Q4 2018, closing a stake of 2,667 shares — an estimated $302K sold.

AMP Capital Investors first reported a position in HAE in Q3 2017 and held it in 3 quarters. The position peaked at $1.12M in Q2 2018. 279 funds tracked by Wall St. Rank hold HAE as of Q4 2018.

  • AMP Capital Investors reported no remaining Haemonetics position as of Q4 2018 after selling out during the quarter.
  • AMP Capital Investors sold 2,667 Haemonetics shares in Q4 2018, an estimated $302K.
  • AMP Capital Investors first reported a position in Haemonetics in Q3 2017 and held it in 3 quarters.
  • AMP Capital Investors's Haemonetics position peaked at $1.12M in Q2 2018.
  • 279 funds tracked by Wall St. Rank held Haemonetics as of Q4 2018.

Based on AMP Capital Investors's 13F filing for Q4 2018, filed 13 Feb 2019.